Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
Abstract Introduction Carbapenems (CR) have traditionally been the first line treatment for bacteremia caused by AmpC-producing Enterobacterales. However, CR have a high ecological impact, and carbapenem-resistant strains continue rising. Thus, other treatment alternatives like Piperacillin-Tazobact...
Saved in:
Main Authors: | M. Ávila-Núñez (Author), O. Lima (Author), A. Sousa (Author), M. Represa (Author), P. Rubiñán (Author), P. Celestino (Author), M. Garrido-Ventín (Author), L. García-Formoso (Author), F. Vasallo-Vidal (Author), L. Martinez-Lamas (Author), A. Pérez-Landeiro (Author), M Rubianes (Author), MT. Pérez-Rodríguez (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales
by: Gianpiero Tebano, et al.
Published: (2024) -
Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study
by: Orjowan Shalabi, et al.
Published: (2024) -
Early Treatment Outcomes for Bloodstream Infections Caused by Potential AmpC Beta-Lactamase-Producing Enterobacterales with Focus on Piperacillin/Tazobactam: A Retrospective Cohort Study
by: Lena Herrmann, et al.
Published: (2021) -
Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020) -
Occurrence, Typing, and Resistance Genes of ESBL/AmpC-Producing <i>Enterobacterales</i> in Fresh Vegetables Purchased in Central Israel
by: Hadas Kon, et al.
Published: (2023)